TesamorelinTesamorelin (INN; trade names Egrifta, Egrifta SV and Egrifta WR) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy, approved initially in 2010. Read from the Drugbox of the Wikipedia article Tesamorelin, revision 1379748585.

Property

Value

Formula

C220H364N72O67S, 5121.81 g/mol

Bioavailability

4 %

Elimination half-life

0.5333 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.